Q-Line Biotech IPO Subscription Status — Day-wise, QIB, NII & Retail
Q-Line Biotech IPO subscription status shows how many times the issue was bid for, split across QIB, NII and retail categories. Here is where to track it and what the figures tell you.
Subscription window: 21 May 2026 to 25 May 2026. Page data as of 9 Oct 2026.
Where to track Q-Line Biotech live subscription
Subscription numbers update through each bidding day. Track them on the NSE and BSE IPO bidding pages, or in your broker's IPO section; this page picks up the exchange's end-of-day figure once bidding starts.
Q-Line Biotech subscription categories explained
- QIB — qualified institutional buyers (mutual funds, banks, FIIs).
- Individual investors — since July 2025 an SME application is exactly two lots (above Rs 2 lakh); this category replaced the old retail bucket and is allotted by lottery when oversubscribed.
- NII — individuals and others bidding more than two lots. The exchange's own table may still print the older labels.
How subscription affects Q-Line Biotech allotment and GMP
The more the retail portion is oversubscribed, the lower each applicant's odds — allotment becomes a lottery for one lot. GMP is unofficial and volatile — never a forecast. See Q-Line Biotech's GMP page and how allotment works in allotment tips.
FAQs
What is Q-Line Biotech IPO subscription status?
Subscription status is how many times Q-Line Biotech has been bid for versus shares on offer, across QIB, NII and retail. The exchange publishes the figure at the end of each bidding day; this page shows it once bidding starts.
Does high subscription mean I will get Q-Line Biotech allotment?
No — the opposite. Heavy retail oversubscription means allotment is by lottery, so your odds fall. High subscription signals demand, but does not improve your individual allotment chance.